This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC

92 views
September 25, 2024
0 Comments
Login to view comments. Click here to Login